These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4634627)

  • 1. Should the FDA impose relative efficacy judgments?
    Stetler CJ
    Tex Med; 1972 Nov; 68(11):48-52. PubMed ID: 4634627
    [No Abstract]   [Full Text] [Related]  

  • 2. Current trends in IND-NDA procedures.
    Brilhart KB
    Bull Parenter Drug Assoc; 1971; 25(3):132-9. PubMed ID: 5093249
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA 'efficacy' rule: does it work?
    Lasagna L
    Mo Med; 1971 Sep; 68(9):712-4. PubMed ID: 5570164
    [No Abstract]   [Full Text] [Related]  

  • 4. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New classification of drugs.
    J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956
    [No Abstract]   [Full Text] [Related]  

  • 6. Toward more effective drug regulation.
    Schmidt AM
    FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532
    [No Abstract]   [Full Text] [Related]  

  • 7. Preclearance of drug products--pharmacy's perspective.
    Feldmann EG
    Am Pharm; 1981 Jun; NS21(6):26-32. PubMed ID: 7246421
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to the applicability of proposed large volume parenteral regulations to small volume parenteral drug products.
    Bull Parenter Drug Assoc; 1976; 30(6):265-79. PubMed ID: 1000103
    [No Abstract]   [Full Text] [Related]  

  • 9. Counterfeit drugs.
    Rudolf PM; Bernstein IB
    N Engl J Med; 2004 Apr; 350(14):1384-6. PubMed ID: 15070787
    [No Abstract]   [Full Text] [Related]  

  • 10. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotics standards versus standards for other drugs.
    Wright WW
    Am J Hosp Pharm; 1982 Jun; 39(6):1046-7. PubMed ID: 7102691
    [No Abstract]   [Full Text] [Related]  

  • 12. Curbing counterfeit drugs.
    FDA Consum; 2006; 40(5):11. PubMed ID: 17326307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic vs. brand name drugs--defining and enforcing standards.
    Lasagna LC
    Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA urged to establish "provisional approval" system for new drugs.
    Odne MA; Jeffrey LP
    Hosp Formul; 1976 Jul; 11(7):346. PubMed ID: 1026691
    [No Abstract]   [Full Text] [Related]  

  • 15. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?
    Moxley JH; Yingling GL; Edwards CC
    Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750
    [No Abstract]   [Full Text] [Related]  

  • 16. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Theoretical and practical aspects of statistic sampling and related norms of acceptance].
    Mattei A; Pietra E
    Boll Chim Farm; 1968 May; 107(5):287-95. PubMed ID: 5721540
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA pressure?
    Appleton BL
    Nature; 1990 Mar; 344(6262):99. PubMed ID: 2308647
    [No Abstract]   [Full Text] [Related]  

  • 20. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.